Abstract
Functional medicine focuses on optimizing health and wellness. Evaluation of health is based on therapeutic partnership between the patient and clinician. Together they dive deep into the patient’s potential clinical imbalances in these seven key areas:
-
1.
Assimilation/gastrointestinal
-
2.
Immune
-
3.
Energy
-
4.
Detoxification
-
5.
Cardiovascular/lymphatic
-
6.
Hormones/neurotransmitter
-
7.
Musculoskeletal/cellular structure
This chapter will explore the links between each of these areas and acne/rosacea. For example, we will discuss how acne is related to oxidative stress and that how dairy and a high-glycemic load diet clearly trigger or exacerbate acne in most of those with a genetic susceptibility to the disease. Additionally, we will explore topics such as links between small bacterial overgrowth and acne/rosacea, how red and blue light treatments help improve acne, the association of dioxin exposure and acne, the mechanisms of how stress triggers acne, the relationship between rosacea and cardiovascular disease, and the role of the skin barrier in acne and rosacea. By unveiling these deeper root causes of acne and rosacea, focus areas for personalized treatment can be developed. In collaboration, the patient and clinician decide on priorities and goals for treatment. Implementation of treatment regimens is focused on lifestyle factors as well as prescription treatments. The potential lifestyle factor areas that are addressed include:
-
Sleep and relaxation
-
Exercise and movement
-
Nutrition (food, vitamins, minerals, supplements, botanicals, etc.)
-
Stress management
-
Relationships and community connections
-
Environmental factors (quality of air, water, etc.)
-
Mental factors (cognition, perception, and psychosocial factors),
-
Emotional factors (awareness and regulation of emotions)
-
Spiritual connections (sense of purpose and meaning)
Collaboration with other practitioners to fully address areas of lifestyle factors is commonly implemented to ensure optimal health outcomes.
The doctor of the future will give no medication, but will interest his patients in the care of the human frame, diet and in the cause and prevention of disease.
―Thomas A. Edison
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
National Rosacea Society. Rosacea dairy booklet. [Online] Available at: https://www.rosacea.org/patients/materials/rosacea-diary-booklet
American Academy of Dermatology. Available at: aad.org/public. Accessed 2011.
Fulton JE, Plewig G, Kligman AM. Effect of chocolate on acne vulgaris. JAMA. 1969;210(11):2071–4.
Anderson PC. Food as the cause of acne. Am Fam Physician. 1971;3:102–3.
Juhl CR, Bergholdt HKM, Miller IM, Jemec GBE, Kanters JK, Ellervik C. Dairy intake and acne vulgaris: a systematic review and meta-analysis of 78,529 children, adolescents, and young adults. Nutrients. 2018;10(8):1049.
Barbieri JS, Spaccarelli N, Margolis DJ, James WD. Approaches to limit systemic antibiotic use in acne: systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments. J Am Acad Dermatol. 2019;80(2):538–49.
Melnik B. Linking diet to acne metabolomics, inflammation and comedogenesis. An update. Clin Cosmet Investig Dermatol. 2015;8:371–88.
Agamia NF, Abdallah DM, Sorour O, Mourad B, Younan DN. Skin expression of mammalian target of rapamycin and forkhead box transcription factor 01, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet. Br J Dermatol. 2016;174:1299–307.
Moran A, Jacobs DR, Steinberger J, Hong CP, Prineas R, Luepker R, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48(10):2039–44.
Schmitt JV, Masuda PY, Miot HA. Acne in women: clinical patterns in different age-groups. An Bras Dermatol. 2009;84:349–54.
Jenkins DJA, Kendall CWC, Augustin LSA, et al. Glycemic index: overview of implications in health and disease. Am J Clin Nutr. 2002;76:226S–73S.
Kaufman WH. The diet and acne. Arch Dermatol. 1983;119:276.
Anderson JW, O’Neal DS, Riddell-Mason S, Floore TL, Dillon DW, Oeltgen PR. Postprandial serum glucose, insulin and lipoprotein responses to high- and low-fiber diets. Metabolism. 1995;44(7):848–54.
Hoyt G, Hickey MS, Cordain L. Dissociation of the glycaemic and insulinaemic responses to whole and skimmed milk. Br J Nutr. 2005;93(2):175–7.
Heaney RP, McCarron DA, Dawson-Hughes B, Oparil S, Berga SL, Stern JS, et al. Dietary changes favorably affect bone remodeling in older adults. J Am Diet Assoc. 1999;99(10):1228–33.
Ben-Amital D, Laron Z. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne. J Eur Acad Dermatol Venereol. 2011;25(8):950–4.
Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008;6:759–64.
Chedid V, Dhalla S, Clarke JO, Roland BC, Dunbar KB, Koh J, et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014;3(3):16–24.
Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the gut-skin axis. Front Microbiol. 2018;9:1459.
Melnik B. Acne and genetics. In: Zouboulis CC, Christos C, Katsambas AD, Kligman AM, editors. Pathogenesis and treatment of acne and rosacea. Berlin: Springer-Verlag; 2014. p. 109–30.
Block ML, Zecca L, Hong JS. Microglia-medicated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57–69.
Arican O, Kurutas EB, Sasmaz S. Oxidative stress in patients with acne vulgaris. Mediat Inflamm. 2005;2005(6):380–4.
Abdel FNS, Shaheen MA, Ebrahim AA, El Okda ES. Tissue and blood superoxide dismutase activities and malondialdehyde levels in different clinical severities of acne vulgaris. Br J Dermatol. 2008;159(5):1086–91.
Amer M, Bahgat MR, Tosson Z, Abdel Mowla MY, Amer K. Serum zinc in acne vulgaris. Int J Dermatol. 1982;21(8):481–4.
Labadarios D, Cilliers J, Visser L, Van Stuijvenberg ME, Shephard GS, Wium D, et al. Vitamin A in acne vulgaris. Exp Dermatol. 1987;12(6):432–6.
Di Landro A, Cazzaniga S, Cusano F, Bonci A, Carla C, Musumeci ML, et al. Adult female acne and associated risk factors: results of a multicenter case-control study in Italy. J Am Acad Dermatol. 2016;75(6):1134–41.
Jung JY, Kwon HH, Hong JS, Yoon JY, Park MS, Jang MY, et al. Effect of dietary supplementation with Omega-3 fatty acid and gamma-linolenic acid on acne vulgaris: a randomised, double blind, controlled trial. Acta Derm Venereol. 2014;94(5):521–5.
Tafur J, Mills PJ. Low-intensity light therapy: exploring the role of redox mechanisms. Photomed Laser Surg. 2008;26(4):323–8.
Na JI, Suh DH. Red light phototherapy alone is effective for acne vulgaris: randomized, single-blinded clinical trial. Dermatol Surg. 2007;33:1228–33.
Arakane K, Ryu A, Hayashi C. Singlet oxygen (1 delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation. Biochem Biophys Res Commun. 1996;223:578–82.
Tzung TY, Wu KH, Huang ML. Blue light phototherapy in the treatment of acne. Photodermatol Photoimmunol Photomed. 2004;20:266–9.
Kwon HH, Lee JB, Yoon JY, Park SY, Ryu HH, Park BM, et al. The clinical and histological effect of home-use, combination blue-red LED phototherapy for mild-to-moderate acne vulgaris in Korean patients: a double-blind, randomized controlled trial. Br J Dermatol. 2013;168(5):1088–94.
Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000;142:973–8.
Goldberg DJ, Russell BA. Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris. J Cosmet Laser Ther. 2006;8:71–5.
Lee SY, You CE, Park MY. Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV. Lasers Surg Med. 2007;39:180–8.
Coenraads PJ, Olie K, Tang NJ. Blood lipid concentrations of dioxins and dibenzofurans causing chloracne. Br J Dermatol. 1999;141:694–7.
Bond GG, McLaren EA, Brenner FE, Cook RR. Incidence of chloracne among chemical workers potentially exposed to chlorinated dioxins. J Occup Med. 1989;31:771–4.
Ma J, Kannan K, Cheng J, Horii Y, Wu Q, Wang W. Concentrations, profiles, and estimated human exposures for polychlorinated dibenzo-p-dioxins and dibenzofurans from electronic waste recycling facilities and a chemical industrial complex in Eastern China. Environ Sci Technol. 2008;42(22):8252–9.
Coenraads PJ, Brouwer A, Olie K, Tang N. Chloracne. Some recent issues. Dermatol Clin. 1994;12(3):569–76.
Fabbrocini G, Kaya G, Caseiro Silverio P, De Vita V, Kaya A, Fontao F, et al. Aryl hydrocarbon receptor activation in acne vulgaris skin: a case series from the region of Naples, Italy. Dermatology. 2015;231:334–8.
Kim YJ, Moon SM, Yang YJ, et al. Single nucleotide polymorphisms in the β-carotene 15,15-monooxygenase coding gene and health outcomes in Korean adults. FASEB. 2012;26:824–13.
Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72(5):749–58; quiz 759–60.
Holmes AD, Spoendlin J, Chien AL, Baldwin H, Chang ALS. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol. 2018;78(1):156–66.
Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):2–11.
Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015;72(5):761–70; quiz 771–2.
Rainer BM, Fischer AH, Luz Felipe da Silva D, Kang S, Chien AL. Rosacea is associated with chronic systemic diseases in a skin severity–dependent manner: results of a case-control study. J Am Acad Dermatol. 2015;73(4):604–8.
Haber R, El Gemayel M. Comorbidities in rosacea: a systematic review and update. J Am Acad Dermatol. 2018;78(4):786–792.e8.
Aldrich N, Gerstenblith M, Fu P, Tuttle MS, Varma P, Gotow E, et al. Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins. JAMA Dermatol. 2015;151(11):1213–9.
Dosal JR, Rodriguez GL, Pezon CF, Li H, Keri JE. Effect of tetracyclines on the development of vascular disease in veterans with acne or rosacea: a retrospective cohort study. J Invest Dermatol. 2014;134(8):2267–9.
Dosal J, Keri J. Rosacea and cardiovascular disease: is there an association? J Am Acad Dermatol. 2015;73(2):308–9.
Marshall VD, Moustafa F, Hawkins SD, Balkrishnan R, Feldman SR. Cardiovascular disease outcomes associated with three major inflammatory dermatologic diseases: a propensity-matched case control study. Dermatol Ther. 2016;6(4):649–58.
Duman N, Ersoy Evans S, Atakan N. Rosacea and cardiovascular risk factors: a case control study. J Eur Acad Dermatol Venereol. 2014;28(9):1165–9.
Hua TC, Chung PI, Chen YJ, Wu LC, Chen YD, Hwang CY, et al. Cardiovascular comorbidities in patients with rosacea: a nationwide case-control study from Taiwan. J Am Acad Dermatol. 2015;73(2):249–54.
Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Assessment of the risk of cardiovascular disease in patients with rosacea. J Am Acad Dermatol. 2016;75(2):336–9.
Kayampilly PP, Wanamaker BL, Stewart JA, Wagner CL, Menon KM. Stimulatory effect of insulin on 5α-reductase type 1 (SRD5A1) expression through an akt-dependent pathway in ovarian granulosa cells. Endocrinology. 2010;151(10):5030–7.
Ganceviciene R, Graziene V, Fimmel S, Zouboulis CC. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol. 2009;160:345–52.
Ma X, Yue ZQ, Gong ZQ, Zhang H, Duan NY, Shi YT, et al. The effect of diaphragmatic breathing on attention, negative affect and stress in healthy adults. Front Psychol. 2017;8:874.
Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next morning. Sleep. 1997;20:865–70.
Wu TQ, Mei SQ, Zhang JX, Gong LF, Wu FJ, Wu WH, et al. Prevalence and risk factors of facial acne vulgaris among Chinese adolescents. Int J Adolesc Med Health. 2007;19(4):407–12.
Donga E, van Dijk M, van Dijk JG, Biermasz NR, Lammers GJ, van Kralingen KW, et al. A single night of partial sleep deprivation induces insulin resistance in multiple pathways in healthy subjects. J Clin Endocrinol Metab. 2010;95(6):2963–8.
Pappas A, Kendall AC, Brownbridge LC, Batchvarova N, Nicolaou A. Seasonal changes in epidermal ceramides are linked to impaired barrier function in acne patients. Exp Dermatol. 2018;27:833–6.
Neukam K, De Spirt S, Stahl W, Bejot M, Maurette JM, Tronnier H, et al. Supplementation of flaxseed oil diminishes skin sensitivity and improves skin barrier function and condition. Skin Pharmacol Physiol. 2011;24(2):67–74.
Ueda O, Hasegawa M, Kitamura S. Distribution in skin of ceramide after oral aministration to rats. Drug Metab Pharmacokinet. 2009;24(2):180–4.
Kimata H. Improvement of atopic dermatitis and reduction of skin allergic responses by oral intake of konjac ceramide. Pediatr Dermatol. 2006;23:386–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jeffries, M., Goldberg, M., Treloar, V. (2021). Functional Medicine Approaches. In: Rupani, R.N., Lio, P.A. (eds) Integrative Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-58954-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-58954-7_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58953-0
Online ISBN: 978-3-030-58954-7
eBook Packages: MedicineMedicine (R0)